For research use only. PeptaBase is for informational and laboratory research reference only. No medical claims are made and nothing on this site is intended to diagnose, treat, cure or prevent any disease.
PeptaBase
500+ PubMed CitationsNo Affiliate LinksPrivate & Secure
The Lab

TB-500 (Thymosin Beta-4): Evidence for Tendon and Muscle Repair

PeptaBase Research Review | 2026-03-07

Introduction

TB-500 is a synthetic copy of a part of Thymosin Beta-4, a natural protein that binds to actin. Research focuses on its role in cell movement, blood vessel growth, and tissue healing.

Most studies use animal models of tendon injury, muscle damage, and inflammation.

For protocol summaries and pharmacokinetic data see the PeptaBase entry: TB-500 entry on PeptaBase

What Thymosin Beta-4 Is

Thymosin Beta-4 is a 43-amino-acid natural peptide that regulates the cell's inner structure (cytoskeleton) and cell movement. TB-500 is a shorter synthetic version designed to mimic its effects.

Research covers:

  • Wound healing
  • Heart injury
  • Muscle repair
  • Inflammation control

Mechanisms Studied

Actin and cell structure

TB-500 binds actin and reorganizes the cell's skeleton, enabling cells to move and repair tissue.

Blood vessel growth

Studies show TB-500 boosts vascular growth factors, promoting new blood vessels during healing.

Anti-inflammatory

Some evidence suggests TB-500 calms inflammatory signals during tissue repair.

Evidence From Tendon and Muscle Studies

Tendon injury

Rodent studies show TB-500 increases cell movement and tissue remodeling markers after tendon injury.

Muscle recovery

Animal muscle injury models show TB-500 boosts satellite cell activity and muscle regeneration.

Research Protocol Observations

Protocols come from animal studies, not human trials. Typical approaches use repeated doses over several weeks, measuring collagen and blood vessel markers.

See PeptaBase for details: TB-500 entry on PeptaBase

Limitations

All the strong data is from animals. The tissue repair pathways are well understood, but we lack large human trials.

Key References